📧 Communication

phone

← Back to List

Communication Details

From

Not specified Linked to Not specified

Public/Interested Parties in the UK Public/Interested Parties in the UK

Subject

Contact Number

Message Content

+44 (0) 203 107 0289

📄 Source Document

HOUSE_OVERSIGHT_026366.jpg

ESTATE Collection

View Document

Document Summary

This document is a corporate communication and product information sheet for the prescription drug Praluent (alirocumab), manufactured by Sanofi. It details the ODYSSEY clinical trial program, provides important safety information for patients, and includes a legal disclaimer. The document is marked with the identifier 'HOUSE_OVERSIGHT_026366' but contains no information whatsoever related to Jeffrey Epstein, his associates, finances, or travel.

Discussion 0

No comments yet

Be the first to share your thoughts on this epstein communication